Psychedelics MindMed doses first patient with MDMA-like compounds in new trial New study will compare the effects of MDA and MDMA in humans for the first time Rowan DunneSeptember 20, 2022
International PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies Organization to supply GMP product for second major clinical trial down under this month Rowan DunneAugust 31, 2022
Canada PharmAla Biotech applies for patent on 6 novel MDMA-like molecules Application follows successful pre-clinical animal studies at the University of Arkansas Rowan DunneAugust 29, 2022
International Mind Medicine Australia receives AUD$1M grant for psychedelic research New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions Rowan DunneAugust 23, 2022
Canada PharmAla Biotech becomes first public company producing GMP MDMA Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial Rowan DunneAugust 22, 2022
Psychedelics Phillips Lytle announces the inception of its Psychedelic & Mental Health Therapies Practice New York law firm forms multidisciplinary association intended to serve the psychedelic industry Rowan DunneAugust 19, 2022
Canada Optimi receives amendment from Health Canada permitting MDMA production Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies Rowan DunneAugust 16, 2022
Canada PharmAla Biotech initiates MDMA supplier agreement with InterVivo Biotechnology company will supply InterVivo and clients with clinical-grade MDMA for scientific analyses Rowan DunneAugust 5, 2022
Psychedelics Sage Institute receives grant to help continue its psychedelic therapy in California Cohen Foundation proudly supports organization dedicated to aiding underserved communities Rowan DunneJuly 27, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022